Illumina expands clinical oncology portfolio unlocking new standard of care and access to precision therapies

www.illumina.com/company/news... Congratulations to Illumina on their expanded diagnostic tools for facilitating precision medicine in cancer treatment. It is critical to get the right treatment to the right patient at the right time. #Illumina #SanDiego #Biotech #Oncology #Cancer #PrecisionMedicine

San Diego's Life Sciences Ecosystem Faces Federal Funding Crisis: Prebys Foundation Announces $7 Million in Emergency Support for Biomedical Research /PRNewswire/ -- As federal funding for medical and life sciences research faces deep and destabilizing cuts, Prebys Foundation is stepping in with a rapid...

www.prnewswire.com/news-release... Thank you to the Prebys Foundation for supporting Biomedical Research here in San Diego! #SanDiego #Biotech #PrebysFoundation

“Digital Tumors” for Precision Oncology: UC San Diego Receives Award from ARPA-H As part of ARPA-H's landmark ADAPT initiative, UC San Diego researchers will develop cutting-edge tools for precision oncology that act as

today.ucsd.edu/story/digita... Great news from UCSD on their ARPA-H award for an innovative approach to advance precision medicine for cancer patients. It's all about getting the right treatment to the right patient at the right time. #SanDiego #Cancer #PrecisionMedicine #UCSD

endeavorbiomedicines.com/endeavor-bio... Encouraging results from Endeavor in a Phase 2a clinical trial for Idiopathic Pulmonary Fibrosis (IPF)! With few good treatment options, it is great to see positive data. #SanDiego #Biotech #IPF #EndeavorBioMed

Cancer drug finds new purpose in the brain - Sanford Burnham Prebys Scientists show that a cancer drug travels to and shrinks some brain tumors, which may lead to new therapies.

sbpdiscovery.org/cancer-drug-... Important and encouraging early results from SBP with a new treatment for brain tumors. The blood brain barrier is a major hurdle for treating gliomas so this drug may be helpful for certain patients. #GBM #SBP #SanDiego #Biotech #Cancer #PrecisionMedicine

UC San Diego Moores Cancer Center Receives $1M Donation from Pfizer for Early Cancer Detection Moores Cancer Center has received a $1 million donation from pharmaceutical company Pfizer to support an innovative new program designed to bolster early cancer detection and prevention efforts.

today.ucsd.edu/story/moores... Early detection of cancer leads to the best possible outcomes. Thank you Pfizer and UCSD Moores for your efforts to improve early detection and help cancer patients in San Diego and around the world. #Pfizer #UCSD #Cancer #Diagnostics #SanDiego #Biotech

Salk Institute receives $4.5 million gift from Trustee Richard A. Heyman to enable early-stage innovative research - Salk Institute for Biological Studies LA JOLLA—Richard A. Heyman, a member of the Salk Institute’s Board of Trustees, and his wife, Anne Daigle, have donated $4.5 million to establish the new Richard A. Heyman Collaborative Innovation Fun...

www.salk.edu/news-release... Congratulations to the Salk Institute on the gift from Richard Heyman. Dr. Heyman is a biotech luminary and continues his tireless efforts to advance biotechnology in San Diego. Thank you for all of your great work! #SalkInstitute #SanDiego #Biotech

A New Way to Predict Cancer’s Spread? Scientists Look at ‘Stickiness’ of Tumor Cells By assessing how “sticky” tumor cells are, UC San Diego researchers have found a potential way to predict whether a patient’s early-stage breast cancer is likely to spread. The discovery could help do...

today.ucsd.edu/story/a-new-... Cool new technology out of UCSD to help doctors identify which early stage breast cancer patients are most at risk for tumor spread and tailor more aggressive treatments to high-risk patients. #UCSD #Cancer #BreastCancer #SanDiego #Biotech #PrecisionMedicine

UC San Diego Climbs to No. 3 Public University in U.S. in Academic Ranking of World Universities UC San Diego has been ranked No. 3 among public U.S. universities in the 2024 Academic Ranking of World Universities released by ShanghaiRanking Consultancy. The university also advanced to No. 14 amo...

today.ucsd.edu/story/uc-san... Congratulations to UCSD as it climbs to top 3 public US Universities in a ranking of 2500 universities worldwide. #UCSD #SanDiego #Biotech #Tech

Curebound Concert for Cures: Elton John | San Diego Padres The Official Site of Major League Baseball

www.mlb.com/padres/ticke... Congratulation to Curebound on the great news of securing Elton John to perform at Curebound Concert for Cures! Let's all get behind this effort to raise money for curing cancer! #Curebound #SanDiego #Cancer #Biotech #EltonJohn

UC San Diego Researchers Awarded $5M Grant to Advance Next-Generation Brain Implants A UC San Diego-led team has been awarded a $5 million grant from the National Institutes of Health (NIH) to develop next-generation brain implants that can record activity deep inside the brain with i...

today.ucsd.edu/story/uc-san... Very cool technology out of UCSD (with collaborators at Salk, MIT, Stanford and Columbia among others) to advance our understanding of neuroscience #UCSD #SalkInstitute #SanDiego #Biotech #Neuroscience

UC San Diego ranks top 10 in world for universities driving innovation The local university was ranked highly for its large volume of patents derived from research activities.

www.sandiegouniontribune.com/2025/02/18/u... UCSD is a San Diego icon and is a powerhouse in research and innovation. Congratulations on the top 10 ranking and for advancing tech, healthcare and beyond to improve lives throughout the world! #UCSD #SanDiego #Biotech #Tech #Innovation

Prebys Foundation Establishes $50M Fund to Invest in Tech, Life Sciences Startups The Conrad Prebys Foundation has launched the Prebys Ventures Impact Fund, a $50 million fund to drive growth and tech advancement.

timesofsandiego.com/tech/2025/02... This is great news for the San Diego Tech and Life Science startup community. Thank you to the Prebys Foundation for their generosity and vision! #SanDiego #Startup #VC #PrebysFoundation

Curebound awards two grants to Sanford Burnham Prebys scientists - Sanford Burnham Prebys The San Diego-based philanthropic organization has awarded $43 million in cancer research to date.

sbpdiscovery.org/curebound-aw... Curebound is doing great work funding innovative science in San Diego. Congratulations to Drs. Emerling, Vijayanand and Jackson on a novel approach to target p53 and to boosting the immune system to combat cancer! #SanDiego #Biotech #Cancer #Curebound

Aardvark Therapeutics Gets $94 Million IPO to Power Obesity Treatments Obesity drug developers Aardvark, Helicore and Metsera have all netted raises in the past two weeks.

www.biospace.com/business/aar... Congratulations to Aardvark on their successful IPO to advance a novel approach for obesity! This is another encouraging sign that the IPO window may be starting to open. #SanDiego #Biotech #Pharma #Obesity #VC

UC San Diego Professor Honored by Sony and Nature for Bioengineering Research Bioengineering Professor Kiana Aran is one of three inaugural winners of the Sony Women in Technology Award with Nature. She is recognized for her pioneering work fusing biology with electronics to en...

today.ucsd.edu/story/uc-san... Congratulations to Dr. Aran for her award by Sony and Nature for a very cool and innovative application of CRISPR to detect genetic mutations in real time #UCSD #Biotech #SanDiego #CRISPR #PrecisionMedicine

Kura and Kyowa hail phase 2 win for leukemia drug soon heading to FDA, but hold back data Kura Oncology and Kyowa Kirin

www.fiercebiotech.com/biotech/kura... Congratulation to Kura and Kyowa on the good news! This would be a great step forward for leukemia patients #SanDiego #Biotech #Cancer #Leukemia

AbbVie and Neomorph Announce Collaboration to Develop Molecular Glue Degraders for Oncology and Immunology /PRNewswire/ -- AbbVie (NYSE: ABBV) and Neomorph, Inc. today announced a collaboration and option-to-license agreement to develop novel molecular glue...

www.prnewswire.com/news-release... Good news about another innovative strategy to go after difficult/"undruggable" proteins through targeted degradation. Let's keep expanding the toolbox to go after cancer targets #SanDiego #Biotech #Cancer #Oncology

After a 'reset' year for M&A, expect bigger deals in 2025: reports The biopharma industry’s deal-a-palooza, better known as the J.P. Morgan Healthcare Conference, has kicked off in San Francisco. | While there was plenty of M&A activity in 2024, many recent deals hav...

www.fiercepharma.com/pharma/after... With plenty of dry powder on hand and patent expiries looming for big Pharma, 2025 could be a strong year for M&A #Biotech #Pharma #SanDiego #M&A

Curebound Closes 2024 by Awarding 17 New Cancer Research Grants, Bringing Total Annual Funding to $8.25M Curebound awarded 17 grants last month for a total of $8.25 million awarded to advance cancer research in 2024.

www.businesswire.com/news/home/20... This is a fantastic news and is such an amazing resource to advance innovative cancer research for patients and companies. Thank you to the Curebound team for their great work! #SanDiego #Biotech #VC #Curebound

Genetic Tweak Optimizes Drug-making Cells by Blocking Buildup of Toxic Byproduct Scientists led by UC San Diego have developed a new strategy to enhance pharmaceutical production in Chinese hamster ovary (CHO) cells, which are commonly used to manufacture protein-based drugs for t...

today.ucsd.edu/story/geneti... Nice work by UCSD researchers to reduce lactic acid in CHO cells which could make a significant improvement in yields of important protein drugs. #SanDiego #Biotech #UCSD

Eli Lilly, Andreessen Horowitz link up on $500M biotech venture fund Eli Lilly and venture capital firm Andreessen Horowitz (a16z) are joining forces to create a unique new fund dubbed the Biotech Ecosystem Venture Fund, backed by $500 million of Lilly’s capital.

www.fiercebiotech.com/biotech/eli-... Great news about a new fund from Eli Lilly and Andreessen Horowitz to drive biotech innovation! #SanDiego #Biotech #VentureCapital #VC

Light Horse lassos Novartis partnership worth up to $1B, wrangles $62M series A Light Horse Therapeutics is off to the races, rounding up a $62 million series A and tacking on a Novartis partnership that could reach up to $1 billion in biobucks. | Light Horse Therapeutics is off ...

www.fiercebiotech.com/biotech/ligh... Congratulations to Light Horse on the Novartis partnership and impressive Series A with a great syndicate! Versant continues their great company creation tradition with a novel gene editing oncology play. #SanDiego #Biotech

Uncovering Clues to a Natural Gene-Editing Technique Diversity-generating retroelements are found in the genomes of microorganisms across the globe — from the arctic permafrost to Yellowstone’s hot springs and the human gut. DGRs are able to accelerate ...

today.ucsd.edu/story/uncove... Cool new gene editing technology from #UCSD. It is always great to have more tools in the toolbox. #SanDiego #Biotech

Multiomics startup Pleno raises $25M for commercial launch, plucks new CEO from Illumina Pleno has plenty to talk about. | Pleno plans to launch its Raptor benchtop analyzer early next year, and it's poached Illumina's Vik Vaz to lead its commercialization.

Clever multiomics strategy to improve sensitivity and specificity for cancer and other diagnostics. #SanDiegoBiotech
#Diagnostics #Cancer #VentureCapital

Roche inks $1.5B Poseida buyout, betting off-the-shelf CAR-Ts will democratize access to cell therapies Roche has struck a $1.5 billion deal to | Roche has struck a $1.5 billion deal to buy Poseida Therapeutics. The takeover will establish off-the-shelf cell therapies, which Roche has said can democrati...

www.fiercebiotech.com/biotech/roch...
Congratulations to Poseida! Another great San Diego Biotech company's successful exit demonstrating support for CAR-T in oncology.